Core 1: Administrative Core

核心 1:行政核心

基本信息

项目摘要

SWAN-Aging is designed to determine the extent to which midlife health and characteristics of the menopause transition (MT) affect successful aging in women, including the rate of cognitive decline and the risk of dementia and disability. Studies on aging highlight the midlife (age 40-65 years) as a critical life stage for prevention of cognitive impairment, Alzheimer’s disease, Alzheimer’s disease related dementia, physical disability and multi-morbidity in old age. This U19 proposal will extend follow-up of the Study of Women’s Health Across the Nation (SWAN), a longitudinal study initiated in 1994 to characterize the physiological and psychosocial changes that occur during the MT, into early old age (66-75 years). It will expand data collection to link midlife health characteristics and modifiable risk factors to early and rapid cognitive decline, incidence of mild cognitive impairment, cardiac health, and physical function in early old age. SWAN-Aging will leverage the existing SWAN scientific expertise and organizational structure to create three integrated Projects. Project 1 will evaluate the impact of MT characteristics and midlife health indicators on preservation of cognitive function (avoiding cognitive decline and onset of mild cognitive impairment), sleep, genitourinary and sexual function, and quality of life in early old age; Project 2 will test how the MT relates to cardiac health and cardiovascular disease (CVD) events in women in early old age and test how cardiac health relates to early markers of physical impairment, Alzheimer’s disease, and vascular dementia at a critical period in the lifespan; and Project 3 will examine the role of the MT and midlife characteristics on musculoskeletal health and physical functioning. The specific aims of Administrative Core (Core 1) are to: 1) Provide leadership, strategic planning, and organizational infrastructure for SWAN-Aging; 2) Facilitate investigator interaction, creativity, and productivity; 3) Disseminate SWAN and SWAN-Aging results and enhance translation; 4) Ensure broad use of SWAN data and support career development; and 5) Monitor and protect participant safety. Core 1 will coordinate and support research efforts across the Projects and Cores and will supply the required resources to execute study operations. Core 1 will support an Integrative Sciences Committee that will facilitate cross-cutting investigations of the interrelationships between cognitive, cardiac, and physical function, and their joint impact on activities of daily living disability. Core 1 will also lead a new Translation and Dissemination Committee in which experts in women’s health will develop methods for disseminating rigorous research results focused on the enhancement of physical health and the prevention of dementia and disability for clinical and lay communities. The Administrative Core will provide the structure required for the SWAN-Aging Projects to successfully conduct their studies, produce meaningful research results, and translate clinically relevant findings to facilitate identification of midlife prevention targets to delay or avoid mild cognitive impairment, preserve functioning, maintain independence, and optimize quality of life in early old age.
SWAN-Aging旨在确定中年健康和更年期过渡(MT)特征对女性成功衰老的影响程度,包括认知能力下降的速度以及痴呆和残疾的风险。关于衰老的研究强调,中年(40-65岁)是预防老年认知功能障碍、阿尔茨海默病、阿尔茨海默病相关痴呆、身体残疾和多种疾病的关键生命阶段。这项U19提案将把全国妇女健康研究(SWAN)的后续工作延长至老年早期(66-75岁)。SWAN是1994年发起的一项纵向研究,旨在描述更年期期间发生的生理和社会心理变化。它将扩大数据收集,将中年健康特征和可改变的风险因素与早期和快速的认知能力下降、轻度认知障碍的发生率、心脏健康和老年早期的身体功能联系起来。SWAN- aging将利用现有的SWAN科学专业知识和组织结构来创建三个综合项目。项目1将评估MT特征和中年健康指标对老年早期认知功能(避免认知衰退和轻度认知障碍的发生)、睡眠、泌尿生殖系统和性功能以及生活质量的影响;项目2将测试MT如何与早期老年妇女的心脏健康和心血管疾病(CVD)事件相关,并测试心脏健康如何与生命中关键时期的身体损伤、阿尔茨海默病和血管性痴呆的早期标志物相关;项目3将研究MT和中年特征对肌肉骨骼健康和身体功能的作用。行政核心(核心1)的具体目标是:1)为SWAN-Aging提供领导、战略规划和组织基础设施;2)促进研究者的互动、创造力和生产力;3)传播SWAN和SWAN- aging结果,加强翻译;4)确保SWAN数据的广泛使用,支持职业发展;5)监督和保护参与者的安全。核心1将协调和支持跨项目和核心的研究工作,并将提供执行研究操作所需的资源。核心1将支持一个综合科学委员会,该委员会将促进认知、心脏和身体功能之间相互关系的交叉研究,以及它们对日常生活残疾活动的共同影响。核心1还将领导一个新的翻译和传播委员会,在该委员会中,妇女健康方面的专家将制定方法,传播侧重于增强临床和非专业社区的身体健康和预防痴呆和残疾的严谨研究成果。行政核心将为SWAN-Aging项目提供所需的结构,以成功开展研究,产生有意义的研究结果,并将临床相关发现转化为促进确定中年预防目标,以延迟或避免轻度认知障碍,保持功能,保持独立性,并优化老年早期的生活质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Mori Brooks其他文献

ORBITA revisited: what it really means and what it does not?
重新审视 ORBITA:它的真正含义是什么,不是什么?
  • DOI:
    10.1093/eurheartj/ehx796
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    39.3
  • 作者:
    B. Chaitman;Maria Mori Brooks;K. Fox;T. Lüscher
  • 通讯作者:
    T. Lüscher
Relationships between substance use treatment facilities and alcohol-attributable mortality across U.S. counties
美国各县药物使用治疗机构与酒精归因死亡率之间的关系
  • DOI:
    10.1016/j.addbeh.2025.108364
  • 发表时间:
    2025-09-01
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Natalie Sumetsky;Maria Mori Brooks;Jeanine Buchanich;Brooke S.G. Molina;Christina Mair
  • 通讯作者:
    Christina Mair
CULTURING BLASTOCYSTS TO DAY 7 OF DEVELOPMENT YIELDS DECREASED ODDS OF LIVE BIRTH FOLLOWING EUPLOID FROZEN EMBRYO TRANSFER
  • DOI:
    10.1016/j.fertnstert.2024.07.886
  • 发表时间:
    2024-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Belita Opene;Nicole M. Fischer;Alexandra A. Szczupak;Roy G. Handelsman;Julie M. Rios;Maria Mori Brooks;Jiaxuan Duan;Bernadette Paternoster;G. David Ball;Pamela B. Parker;Melissa Lombardozzi
  • 通讯作者:
    Melissa Lombardozzi

Maria Mori Brooks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria Mori Brooks', 18)}}的其他基金

Core 3: Data Collection & Data Management Core
核心 3:数据收集
  • 批准号:
    10471455
  • 财政年份:
    2020
  • 资助金额:
    $ 121.92万
  • 项目类别:
Core 1: Administrative Core
核心 1:行政核心
  • 批准号:
    10471453
  • 财政年份:
    2020
  • 资助金额:
    $ 121.92万
  • 项目类别:
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
  • 批准号:
    10911525
  • 财政年份:
    2020
  • 资助金额:
    $ 121.92万
  • 项目类别:
Core 3: Data Collection & Data Management Core
核心 3:数据收集
  • 批准号:
    10263897
  • 财政年份:
    2020
  • 资助金额:
    $ 121.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    10402934
  • 财政年份:
    2019
  • 资助金额:
    $ 121.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    10163253
  • 财政年份:
    2019
  • 资助金额:
    $ 121.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    9926916
  • 财政年份:
    2019
  • 资助金额:
    $ 121.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    10642928
  • 财政年份:
    2019
  • 资助金额:
    $ 121.92万
  • 项目类别:
Myocardial Ischemia and Transfusion (MINT) - DCC
心肌缺血和输血 (MINT) - DCC
  • 批准号:
    10290738
  • 财政年份:
    2016
  • 资助金额:
    $ 121.92万
  • 项目类别:
Treatment and Risk Factor Determinants of Cardiovascular Outcomes in BARI 2D
BARI 2D 心血管结局的治疗和危险因素决定因素
  • 批准号:
    8625130
  • 财政年份:
    2013
  • 资助金额:
    $ 121.92万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 121.92万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 121.92万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 121.92万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 121.92万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 121.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 121.92万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 121.92万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 121.92万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 121.92万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 121.92万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了